11th Edition of World Congress on Infectious Diseases
June 28-30, 2027 | Rome, Italy
Innovative Therapies and Drug Discovery
The future of treating infectious diseases lies in innovative therapies and drug discovery, where new scientific advancements are reshaping treatment landscapes. As drug resistance continues to rise and new pathogens emerge, the need for alternative therapeutic options has never been more critical. Researchers in the realm of innovative therapies and drug discovery are exploring a variety of methods, from developing small molecules that target bacterial resistance mechanisms to designing vaccines that can preemptively neutralize infections. Breakthroughs in biotechnology and molecular biology are making it possible to rapidly identify potential drug candidates and accelerate clinical trials. This progress holds the promise of more effective, efficient, and accessible treatments to address infectious diseases on a global scale.
Ranjan Ramasamy
ID-FISH Technology, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Elena Chiappini
University of Florence, Italy
Saurabh Chattopadhyay
University of Kentucky College of Medicine, United States
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Masafumi Seki
Saitama Medical University International Medical Center, Japan
Martha Grace McLean
Anne Burnett Marion School of Medicine at Texas Christian University, United StatesSubmit your abstract Today
Title : Diagnostic approaches, predictive and prognostic assessments, monitoring, treatment & management of infectious diseases and disease prevention
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The accelerated timeline: Human ecology, climate change, and the next global outbreak
Claudia Ferreira, Sorbonne University, France
Title : Climate change and increasing death due to resistant infection
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Recurrent klebsiella pneumoniae pyogenic liver abscess: Developing a literature-informed 0–2 scoring framework from a solved index case
Martha Grace McLean, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Post-hysterectomy pelvic abscess mimic: An AI-assisted diagnostic stewardship workflow
Setu Shiroya, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Building a clinical reasoning tool from post-transplant MRSA sepsis: A mentored ai workflow
Michaela Mitchell, Anne Burnett Marion School of Medicine at Texas Christian University, United States